Legal News

MHRA decides against reclassification of Aquiette 2.5mg Tablets

Published on: 11 May 2023
Published by LNB News

LNB News 11/05/2023

Document Information

Issue Date: 11 May 2023

Published Date: 11 May 2023

Jurisdiction(s): England, Northern Ireland, Scotland and Wales

Article summary

The Medicines and Healthcare products Regulatory Agency (MHRA) has decided to maintain the status of Aquiette 2.5mg Tablets as a prescription-only medicine and not to reclassify as a pharmacy medicine. In assessing the reclassification application, this concluded that a medical prescription is still required to ensure the safe use of Aquiette. Patients can still access the medicine with a prescription from a qualified healthcare professional.

Popular documents